Pharmacoepidemiology - Policy and Economic Issues
Covers a wide range of issues: regulation and legislation relevant to pharmaceuticals; the pharmaceutical industry; affordability and equity of access to therapeutic drugs; the assessment of the cost-effectiveness of drugs; and the incorporation of these elements into national drug policies.
Faculty of Health and Medicine
School of Medicine and Public Health
Semester 2 - 2015
On successful completion of this course, students will be able to:
- An understanding of the basic elements of legislation governing the production or importation of pharmaceutical products.
- An understanding of the minimum requirements for legislation and regulation to ensure the quality of pharmaceutical products.
- An understanding of the basic elements of drug evaluation to ensure an adequate balance between efficacy, safety and quality of pharmaceutical products.
- An understanding of the pharmaceutical industry, and its place in modern societies.
- An understanding of the basic elements of pharmacoeconomic analysis.
- And understanding of how all of these elements are incorporated in comprehensive national medicinal drug policies.
- The ability to perform rapid drug evaluations, and a critical appraisal of published pharmacoeconomic analyses.
Module 1: Drug Policy I: Drug Regulation and Legislation
Module 2: Drug Policy II: Access, Pharmaceutical Industry and Quality Use of Medicines
Module 3: Introduction to Pharmacoeconomics
Module 4: Measurement and Incorporation of Costs in Pharmacoeconomic Analysis
Module 5: Health Related Quality of Life
Module 6: Use of Economic Modelling in Pharmacoeconomic Analysis
Module 7: Use of Pharmacoeconomic Analysis in Decision-Making and Pricing: Price Setting
- Written Assignment: Essays / Written Assignments
- Online Activity: for 2 hour(s) per Week for Full Term (Contact hours are an indication only. Blackboard Discussion and Email discussion as required.)
2015 Course Timetables for EPID6530